Serum biochemical indicator testing is a core analytical service for preclinical studies using mouse models of mastitis, providing quantitative insight into systemic inflammation, liver and kidney function, oxidative stress, and therapeutic efficacy. By measuring enzymes, metabolites, acute-phase proteins, and antioxidant markers in serum, researchers can objectively evaluate disease progression and intervention outcomes. This technical article outlines the sample requirements, testing parameters, analytical methods, and typical applications of serum biochemistry analysis in mice with experimental mastitis, as performed under accredited laboratory quality systems.
Technical Overview
Mastitis is the inflammation of mammary gland tissue and remains one of the most economically significant diseases in dairy production as well as an important subject of biomedical research. Experimental mouse models are widely established through intramammary inoculation of pathogens such as Staphylococcus aureus, Escherichia coli, or Streptococcus uberis, or by local administration of lipopolysaccharide (LPS) to trigger an acute inflammatory cascade. These models reproduce key features of clinical mastitis, including mammary gland edema, neutrophil infiltration, bacterial colonization, and systemic immune activation.
Serum biochemical indicator testing provides a quantitative, systemic perspective on the disease state that complements local histopathological and microbiological findings. During mastitis, inflammatory mediators released from the infected mammary gland drive a hepatic acute-phase response, alter vascular permeability, induce oxidative damage, and may transiently impair liver and kidney function. Measuring serum enzymes, metabolites, acute-phase proteins, and antioxidant capacity therefore allows researchers to grade disease severity, monitor the time course of inflammation, and quantify the protective effects of candidate drugs or natural products.
All animal procedures associated with sample generation should be reviewed and approved by an institutional animal care and use committee (IACUC), and analytical work is typically conducted in accredited third-party laboratories operating under an ISO/IEC 17025 quality management system, ensuring traceable calibrations, validated methods, and reproducible reporting.
Testing Samples
Serum from Mastitis Model Mice
The standard sample type is serum collected from female mice used in the mastitis model, commonly C57BL/6, BALB/c, ICR, or Kunming strains, either lactating (for infection models performed through the teat canal) or nulliparous (for hormone-synchronized or LPS-induced models). Depending on study design, samples are collected from healthy control mice, untreated model controls, and treated intervention groups, often with a baseline bleed prior to challenge.
Blood Collection Techniques
- Retro-orbital sinus or submandibular vein puncture for serial, low-volume sampling under anesthesia.
- Tail vein or saphenous vein collection for repeated longitudinal monitoring.
- Terminal cardiac puncture or abdominal aorta puncture for maximum serum yield at necropsy.
- Typical collection volumes of 0.3–0.8 mL whole blood per adult mouse, yielding approximately 150–400 µL of serum after processing.
Sample Handling and Pre-Analysis Requirements
Whole blood is allowed to clot at room temperature for 30–60 minutes and then centrifuged at 3,000–4,000 rpm for 10–15 minutes at 4 °C. The separated serum is carefully aspirated, aliquoted to avoid repeated freeze–thaw cycles, and stored at −80 °C until analysis. Hemolyzed, lipemic, or microbially contaminated samples should be excluded or flagged, since hemolysis in particular falsely elevates AST, LDH, potassium, and several colorimetric endpoints.
Testing Items
Serum biochemical panels for mastitis mouse studies are typically organized into functional modules selected according to the study objective, whether it is efficacy evaluation, mechanism research, or safety screening.
Hepatic Function Panel
- Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) – markers of hepatocellular injury that frequently rise during systemic inflammation.
- Alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) – biliary and epithelial injury markers.
- Total protein (TP), albumin (ALB), globulin, A/G ratio, and total bilirubin (TBIL) – reflect acute-phase protein shifts and hepatic synthetic function.
Renal Function Panel
- Blood urea nitrogen (BUN) and creatinine (CREA) – glomerular filtration markers that may increase with severe systemic inflammation or dehydration.
- Uric acid (UA) – an additional metabolic and renal marker with antioxidant relevance.
Inflammatory and Acute-Phase Markers
- C-reactive protein (CRP) and serum amyloid A (SAA) – major murine acute-phase proteins that rise sharply after mammary challenge.
- Myeloperoxidase (MPO) activity – an indicator of neutrophil activation and infiltration.
- Nitric oxide (NO) and complement C3 – mediators of inflammatory and innate immune responses.
- Serum cytokines including TNF-α, IL-1β, IL-6, IL-10, and KC/CXCL1 – quantified by immunoassay to profile the cytokine storm characteristic of acute mastitis.
Oxidative Stress and Antioxidant Markers
- Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) – enzymatic antioxidant defenses typically depleted during acute infection.
- Malondialdehyde (MDA) – a lipid peroxidation product that increases with reactive oxygen species accumulation in inflamed tissue.
- Reduced glutathione (GSH) and total antioxidant capacity (T-AOC) – global redox status indicators.
Metabolic and Miscellaneous Parameters
- Glucose (GLU), triglycerides (TG), total cholesterol (TCH), HDL-C, and LDL-C – energy and lipid metabolism indices altered by febrile and inflammatory states.
- Electrolytes and minerals, including Na⁺, K⁺, Cl⁻, Ca²⁺, and inorganic phosphorus – acid–base and homeostasis markers.
Testing Methods
Automated Biochemistry Analysis
Routine enzymatic and colorimetric parameters (ALT, AST, ALP, BUN, CREA, GLU, lipids, proteins) are measured on fully automated clinical chemistry analyzers using endpoint, kinetic, or rate methods aligned with internationally recognized IFCC-compatible reagent systems. Each run includes multi-level calibrators and quality control sera, with replicate precision typically required to remain below a 5% coefficient of variation.
ELISA and Immunoassay Detection
Acute-phase proteins and cytokines are quantified using double-antibody sandwich ELISA kits specific to mouse targets. Standard curves are fitted by four-parameter logistic regression, with sample concentrations interpolated within the validated linear range and reported in pg/mL or ng/mL. All samples, standards, and blanks are run in duplicate, and wells exceeding acceptable intra-plate CV thresholds are re-tested.
Spectrophotometric Determination of Antioxidant and Oxidative Markers
Antioxidant enzymes and lipid peroxidation products are measured by established colorimetric methods: xanthine oxidase (WST-1) coupling for SOD activity, the thiobarbituric acid (TBA) reaction for MDA, ammonium molybdate or guaiacol chemistry for CAT, DTNB colorimetry for GSH, and chemiluminescence or colorimetric probes for NO. Assays are read on validated microplate spectrophotometers with wavelength verification before each session.
Quality Assurance and Data Reporting
- All testing workflows follow ISO/IEC 17025-aligned quality systems with documented method validation and instrument calibration.
- Animal grouping, sample coding, and analysis are performed with randomization and blinded assessment to minimize bias.
- Results are reported as mean ± SD or mean ± SEM per group, with inter-group comparisons by one-way ANOVA or non-parametric equivalents and statistical significance set at p < 0.05.
- Deliverables typically include raw absorbance data, calculated concentrations, QC records, standard curves, and graphical summaries.
Applications
Serum biochemical testing in mastitis mouse models supports a broad range of preclinical research and development objectives:
- Drug efficacy evaluation: quantifying how antibiotics, anti-inflammatory agents, or biological therapeutics normalize infection-induced biochemical abnormalities.
- Natural product and functional food research: demonstrating protective effects of plant extracts, polysaccharides, flavonoids, or peptides on inflammatory markers and antioxidant capacity.
- Probiotics and immunomodulator studies: assessing modulation of cytokine profiles and acute-phase responses following preventive or therapeutic administration.
- Vaccine and adjuvant development: correlating serum biomarker suppression with reduced bacterial loads and improved mammary pathology scores.
- Pathogenesis and biomarker discovery: characterizing the systemic time course of LPS- or bacteria-induced inflammation to identify early diagnostic indicators.
- Safety and toxicity screening: confirming that test compounds do not themselves perturb hepatic or renal biochemical parameters.
FAQ
How much serum is required for a comprehensive panel?
Automated chemistry analyzers typically consume 2–20 µL per analyte, so a routine ten-parameter panel can often be completed with 50–150 µL of serum. Adding cytokine ELISAs or antioxidant assays, each of which may require 25–50 µL per target, usually brings the total requirement to 200–400 µL. Terminal cardiac puncture collection is recommended when a full multi-module panel is planned from a single mouse.
When should blood samples be collected relative to model induction?
A baseline sample is collected before challenge where possible. For LPS-induced acute mastitis, peak serum cytokine and acute-phase responses generally occur between 12 and 24 hours, while bacterial infection models are commonly evaluated at 24–48 hours post-inoculation. The optimal window should be confirmed against the specific pathogen, dose, and mouse strain used.
Can hemolyzed or lipemic samples still be analyzed?
Hemolysis interferes with several endpoints, notably AST, LDH, potassium, and MDA, while lipemia affects turbidimetric readings. Mildly affected samples may be reported with qualification, but markedly hemolyzed specimens should be re-collected. Careful puncture technique, adequate clotting time, and gentle centrifugation are the best preventive measures.
How should serum samples be stored and shipped?
Serum should be aliquoted and stored at −80 °C, with no more than one freeze–thaw cycle before analysis. For shipping, samples must be transported frozen on dry ice in insulated containers with temperature monitoring, accompanied by a sample manifest listing collection time, group code, volume, and storage history.
How are the results interpreted?
Biochemical values are interpreted by comparing the untreated mastitis model group with healthy controls to confirm disease induction, and comparing treated groups with the model group to evaluate efficacy. A beneficial intervention typically restores elevated CRP, SAA, cytokines, MDA, and transaminases toward baseline while replenishing SOD, GSH-Px, and T-AOC. Interpretation should always be integrated with mammary histopathology, bacterial clearance, and clinical observations to obtain a complete efficacy picture.